Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Maintaining Neutral Rating with Raised Price Target for SM Energy

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Renewable-energy
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Susquehanna analyst Biju Perincheril has decided to maintain a Neutral rating on SM Energy (NYSE:SM) on February 26, 2024. However, he has raised the price target from $38 to $42, showing a more optimistic view on the stock’s potential performance. This adjustment suggests that Perincheril sees some positive developments ahead for SM Energy.

SM Stock Performance Update: Slight Decrease on February 26, 2024, but Still Strong Compared to Historical Performance

On February 26, 2024, SM stocks showed a slight decrease in performance, with the price dropping by $0.04 since the last market close. This represents a 0.10% decrease in value. The stock opened at $41.23, which was $0.19 lower than its previous close. Despite this slight dip in performance, SM is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, and investors may still have confidence in its potential for growth. It is important for investors to closely monitor the performance of SM stocks in the coming days to see if this slight decrease is a temporary fluctuation or the start of a larger trend. Keeping an eye on market trends and news related to the company can help investors make informed decisions about buying, selling, or holding onto their SM stocks. Overall, while there was a slight decrease in SM stock performance on February 26, 2024, the stock is still showing strength compared to its historical performance. Investors should continue to stay informed and monitor the stock closely to make the best decisions for their investment portfolios.

SM Stock Performance Analysis: Revenue and Net Income Decline in 2024

On February 26, 2024, investors were closely watching the performance of SM stock after the company released its latest financial results. SM reported total revenue of $2.37 billion for the past year, a decrease of 29.32% compared to the previous year. Total revenue remained flat compared to the previous quarter, coming in at $608.73 million for Q4.

SM’s net income for the past year was reported at $817.88 million, showing a decrease of 26.45% from the previous year. Net income also held flat compared to the previous quarter, with Q4 net income coming in at $247.11 million.

Earnings per share (EPS) for SM were reported at $6.86 for the past year, representing a 23.46% decrease from the previous year. EPS remained unchanged compared to the previous quarter, with Q4 EPS reported at $2.12.

Overall, SM’s financial performance showed a decline in key metrics compared to the previous year. However, the company was able to maintain stability in its financial performance compared to the previous quarter. Investors will be monitoring future developments and announcements from SM to assess the company’s growth prospects and potential for improvement in financial performance.

Tags: SM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Enlivex Receives Regulatory Approval for Phase 12 Clinical Study on Allocetra for Knee Osteoarthritis

Finance_Fiscal (3)

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

Biotechnology Stock Market Today (1)

Owlet Announces 9 Million Private Placement Financing Deal with Series B Preferred Stock

Recommended

Procter & Gamble Stock

Insider Selling Spree Raises Questions at Procter & Gamble

4 weeks ago
Emerald Expositions Events Stock

Emerald Expositions Stock: A Surprising Outperformer Gains Momentum

1 month ago
Real Estate Investment Trading online

Potential Surge in Demand for REITs like Boston Properties due to Trumps ProBusiness Policies and Tax Reforms

2 years ago
Food Retailers Stock Bull Market

Beyond Meats Stock Rises After Strong FourthQuarter Results

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Global Equity ETF Heavily Reliant on US Tech Titans

A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF

Lixiang Education Shares Surge Amid Conflicting Market Signals

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

Microsoft Navigates AI Expansion Amid Immigration Policy Shift

Trending

Global X Uranium ETF Stock
Commodities

Is This Uranium ETF the Unseen Champion of Clean Energy Transition?

by Robert Sasse
September 22, 2025
0

As nations worldwide pursue dependable, carbon-free power solutions, a long-overlooked sector is staging a remarkable recovery. The...

KalVista Stock

KalVista’s Regulatory Victory Meets Market Skepticism

September 22, 2025
ASML Stock

ASML Faces Mounting Headwinds as Analyst Sentiment Sours

September 22, 2025
MSCI World ETF Stock

Global Equity ETF Heavily Reliant on US Tech Titans

September 22, 2025
iShares U.S. Aerospace & Defense ETF Stock

A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Is This Uranium ETF the Unseen Champion of Clean Energy Transition?
  • KalVista’s Regulatory Victory Meets Market Skepticism
  • ASML Faces Mounting Headwinds as Analyst Sentiment Sours

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com